Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Stocknosis is a fundamental investment research platform founded in 2025 and headquartered in Sydney. It is aimed at “long-term investors” rather than short-term traders. Its core tagline is “Know What You Own,” emphasizing helping users truly understand the companies they hold, rather than simply viewing market data. Its features are built around company intelligence, financial health, business composition, news updates, AI monitoring, and broker integrations.
Based on the information disclosed, Stocknosis focuses on in-depth financial health analysis, including balance sheet strength, cash flow quality, earnings durability, and capital allocation, using proprietary scores to help users assess a company’s “financial fitness.” It also offers Products & Services Intelligence, aiming to explain what a company actually does, what it sells, and where its revenue comes from—an important part of fundamental research. Its AI-related capabilities include AI-driven thesis validation, AI Monitoring, and AI-Powered Research, but the page does not specify which models it uses, its data sources, generation logic, or validation methods.
The page only shows “Get Early Access,” suggesting the product may still be in an early-access or waitlist stage. The main content does not disclose any free tier, trial period, paid plans, enterprise pricing, or payment methods, so its value for money cannot currently be assessed.
The main strengths are its clear positioning and focus on long-term investment research, covering a complete workflow from understanding a company’s business and assessing financial quality to validating an investment thesis. Its research workflow engine may also suit users who need a more systematic due diligence process. The downside is the lack of disclosure around key details: model capabilities, scoring methodology, data sources, sample outputs, privacy policy, API availability, and the scope of broker integrations are all unclear. Since it is in early access, its maturity and stability still need to be proven.
Stocknosis is better suited to long-term shareholders, individual fundamental investors, and investors who want to build a structured research workflow. It is less suitable for high-frequency trading, quantitative backtesting, or users who only need real-time market data tools.
The page does not provide information about access from mainland China, a Chinese-language interface, or RMB payments, so china_access can only be assessed as unknown. If access or payment is limited, alternatives to consider include Koyfin, TIKR, Simply Wall St, Seeking Alpha, FinChat, or using it alongside local financial data platforms.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on stocknosis.com official site.
stocknosis.com is an Australia AI Apps provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach stocknosis.com directly.